Zobrazeno 1 - 10
of 2 514
pro vyhledávání: '"Jj, Martínez"'
Autor:
J Hernández-Martínez, S Rebollar-Rebollar, R Rojo-Rubio, JA García-Salazar, E Guzmán-Soria, JJ Martínez-Tinajero, MA Díaz-Carreño
Publikováno v:
Ecosistemas y Recursos Agropecuarios, Vol 24, Iss 2 (2014)
La rentabilidad privada y la eficiencia de los costos privados son indicadores de competitividad en las granjas porcinas. El presente estudio se realizó en el Sur del Estado de México en 2006, y se basó en información proveniente de sesenta porci
Externí odkaz:
https://doaj.org/article/b957b8bcae7b4b3cbec977cffc323245
Autor:
JJ Martínez-Tinajero, MT Sánchez Torres-Esqueda, G Torres-Hernández, JG Herrera-Haro, L Bucio-Alanís, R Rojo-Rubio, J Hernández-Martínez
Publikováno v:
Ecosistemas y Recursos Agropecuarios, Vol 24, Iss 3 (2014)
Este experimento se realizó para evaluar el comportamiento reproductivo en ovejas F1 (Damara x Merino) importadas de Australia, sincronizadas con un dispositivo liberador de la hormona (CIDR) y dos tiempos de aplicación de hormona liberadora de gon
Externí odkaz:
https://doaj.org/article/774d078d918f404f8ae8ccbf9dd4ee98
Autor:
L Carrasco Piernavieja, JJ Martínez Simón, S Sanz Márquez, M. D. C. Morales Catalan, M Pérez Encinas, I Plo Seco, S. Lorenzo Martínez, I. Oterino Moreira, E Zhan Zhou, P. Roldan Navarro, I. Salvador Llana
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance In response to the COVID-19 pandemic, scientific societies and regulatory agencies quickly reviewed any available evidence to fill the therapeutic gap In this context, many drugs were used with an uncertain benefit- risk pro
Publikováno v:
Revista argentina de endocrinología y metabolismo, Volume: 57, Issue: 3, Pages: 1-10, Published: SEP 2020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______617::6332f119a9621ee3a41a66d52861d343
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1851-30342020000300003&lng=en&tlng=en
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1851-30342020000300003&lng=en&tlng=en
Autor:
S Álvarez Atienza, M Domínguez Bachiller, Javier, Esther, JJ Martínez Simón, M Renilla Sánchez, M Pérez Encinas, S Sanz Márquez, I Plo Seco
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance Prescription in the emergency department (ED) is compromised by multiple causes which could lead to a higher risk of medication errors. Aim and objectives To compare and analyse pharmaceutical interventions (PIs) performed i
Autor:
M Gil Candel, M I Nicolás de Prado, C Iniesta Navalón, JJ Martínez Crespo, L Rentero Redondo, L Serrano Díaz, R M Gómez Espín
Publikováno v:
Journal of Crohn's and Colitis. 14:S449-S450
Background Ustekinumab (UTK) is a human immunoglobulin (Ig) G1 kappa monoclonal antibody approved in 2017 for the treatment of Crohn’s Disease (CD). Up until now, there has not been enough evidence of the relationship between ustekinumab trough lev
Autor:
JJ Martínez Simón, M Pérez Encinas, MT Martínez Martínez, A Abella Tarazona, C Sobrino Jiménez, F Moreno Ramos, MA Asensio Ruíz, AM Gómez Pedrero, M Soria Soto
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Radium-223 (223Ra) chloride has been shown to improve overall survival (OS) and progression-free survival (PFS) in patients with castration-resistant prostate cancer (CRPC) and bone metastases. Purpose To evaluate the effectiveness and saf
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Allergic asthma is the most prevalent phenotype of severe asthma in which treatment with omalizumab has been proven to be beneficial. Purpose Analyse the effectiveness, efficiency and safety of omalizumab in patients with uncontrolled mode
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Digoxin is a high-alert medication because of its narrow therapeutic range and high drug-to-drug interactions. Fifty per cent of cases of digoxin toxicity can be prevented by improving treatment with digoxin. Purpose Checking whether the d
Autor:
P Sanmartin Fenollera, I Plo Seco, JJ Martínez Simón, P. Roldan Navarro, M Pérez Encinas, I. Oterino Moreira, P Toro Chico
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Nab-paclitaxel was approved for the treatment of metastatic adenocarcinoma of pancreas (mPAC), as a first treatment in combination with gemcitabine Purpose To evaluate the effectiveness and safety of nab-paclitaxel in patients with mPAC in